ÔçÒÒŮѸÀ×

    • <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      
    

    

      PTC Therapeutics Inc
      PTC Therapeutics Inc
      PTCT
      Market Cap$3.92B
       Close$
      
      
      
      
      Compare to Similar Companies
      P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
      PTC Therapeutics IncPTC Therapeutics Inc6.1--305%2.7-2.3
      $68.00
      Target Price by Analysts
      18.8% upsidePTC Therapeutics Target Price DetailsTarget Price
      $29.89
      Current Fair Value
      47.8% downside
      Overvalued by 47.8% based on the discounted cash flow analysis.
      Share Statistics
      Market cap$3.92 Billion
      Enterprise Value$3.38 Billion 
      Dividend Yield$- (-)
      Earnings per Share$-4.73 
      Beta0.54
      Outstanding Shares78,151,240
      Return
      Return on Equity-
      Return on Assets-
      Return on Invested Capital-
      Valuation & Multiples
      P/E Ratio6.13
      PEG-17.7
      Price to Sales2.73
      Price to Book Ratio-19.09
      Enterprise Value to Revenue1.99
      Enterprise Value to EBIT4.17
      Enterprise Value to Net Income5
      Total Debt to Enterprise0.14
      Debt to Equity-2.34
      Revenue Sources
      No data
      Insider Trades
      ESG Score
      No data
      About PTC Therapeutics Inc
      CEO: Stuart Peltz 
      
      
      


    
      
  
      
    

    
  
      

      

    
      
  To improve your user experience we use
  cookies.
  

      

    
  
  
      
  
      

  
  

  

  
  

  
HoMEÔçÒÒŮѸÀ×